Cardiol Therapeutics Files 6-K on April 28, 2026
Ticker: CRDL · Form: 6-K · Filed: Apr 28, 2026 · CIK: 0001702123
| Field | Detail |
|---|---|
| Company | Cardiol Therapeutics Inc. (CRDL) |
| Form Type | 6-K |
| Filed Date | Apr 28, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, 6-K, news-release
TL;DR
Cardiol Therapeutics filed a 6-K on 4/28/26 - check for news.
AI Summary
Cardiol Therapeutics Inc. filed a Form 6-K on April 28, 2026, reporting a news release dated the same day. The filing includes a graphic and the complete submission text file. The company's business address is 602-2265 Upper Middle Road East, Oakville, A6 L6H 0G5.
Why It Matters
This filing provides an update from Cardiol Therapeutics Inc., potentially containing significant news or developments relevant to investors and stakeholders.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign issuer and does not appear to contain significant financial or operational news that would immediately impact risk.
Key Players & Entities
- Cardiol Therapeutics Inc. (company) — Filer
- 0001702123 (company) — CIK
- 0001279569-26-000353 (filing_id) — SEC Accession Number
- April 28, 2026 (date) — Filing Date and Period of Report
FAQ
What type of report is this 6-K filing?
This filing is a Form 6-K, which is a report of a foreign issuer.
When was this filing accepted by the SEC?
The filing was accepted on April 28, 2026, at 07:50:00.
What is the CIK number for Cardiol Therapeutics Inc.?
The CIK number for Cardiol Therapeutics Inc. is 0001702123.
What is the business address of Cardiol Therapeutics Inc.?
The business address is 602-2265 Upper Middle Road East, Oakville, A6 L6H 0G5.
What document types are included in this submission?
The submission includes a FORM 6-K, a NEWS RELEASE DATED APRIL 28, 2026, and a GRAPHIC logo.jpg.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 28, 2026 regarding Cardiol Therapeutics Inc. (CRDL).